List of Diagnostics Companies in South Carolina - 4

ARCpoint Labs is a trusted industry leader serving our communities with drug, alcohol, DNA, and clinical testing solutions. With more than 100 independently owned locations, we are committed to providing accurate, cost-effective solutions for consumers, businesses, and physicians nationwide. As one of the fastest growing third-party administrators for testing solutions, ARCpoint Labs continues to innovate and expand its offerings to better meet the needs of our communities. ARCpoint Labs offers businesses a reliable partner for all drug and alcohol testing, policy development, and supervisory training in addition to convenient SARS-CoV-2 testing solutions. Our offerings are built by our dedication to providing safe and drug/alcohol-free workplaces. Many ARCpoint Labs locations offer affordable walk-in wellness solutions and clinical lab screenings to help individuals take control of their overall health and well-being.

Kiyatec is disrupting cancer care by accurately predicting patient–specific response and non–response before treatment begins. We utilize the patient’s own living tumor cells to create functional 3D models to test a battery of cancer therapies in our CLIA-certified and research laboratories. Our goal is to enable physicians to isolate only the effective treatments for their patients as quickly as possible - making true personalized medicine a reality. Our approach has been validated through engagements with leading cancer hospitals, multiple top 10 pharmaceutical companies and the NCI. We are conducting robust clinical trials to fully demonstrate the power of our approach and earn widespread adoption for a broad portfolio of products predicting response to today’s and tomorrow’s therapies. www.kiyatec.com

Phi Life Sciences is a Molecular Diagnostic and Laboratory Service company that aims to help patients by reducing disease mortality and adverse drug reactions through affordable, state of the art screening and diagnostic technologies. Phi Life Sciences is the bridge between scientists with innovative technologies and the patients and doctors whom they can benefit. We build this bridge through products developed in laboratory services and offered to patients and doctors through clinical services. Phi Life sciences aims to improve the efficiency, delivery, accessibility, and utility of molecular testing services through innovative technologies, licensed products, and clinically actionable result that empower physicians to deliver precision treatments and diagnoses by incorporating molecular tests that will improve their patients' health. Phi Life Sciences aims to improve patient health through the use of cutting edge molecular diagnostic tools. We exist to achieve the human potential.

Spectral Medical is a Phase 3 company advancing the fight against endotoxic septic shock through an innovative theranostic approach. This unique strategy combines the EAA™ Endotoxin Activity Assay, the only FDA-cleared diagnostic for the risk of developing sepsis, with targeted rapid therapy using Toraymyxin™ (PMX). PMX is a Polymyxin B extracorporeal direct hemoadsorption column which is highly effective in removing endotoxin in the bloodstream. Already approved in Japan and Europe (1994 and 2002 respectively), PMX has been safely used on over 340,000 patients. Spectral holds exclusive U.S. development and commercialization rights for PMX since 2009, with a distribution agreement for Canada since 2010. In July 2022, the FDA granted Breakthrough Device Designation to PMX for treating endotoxic septic shock, a condition that affects around 330,000 people in North America annually. Spectral is currently conducting the Tigris Trial, a confirmatory study evaluating PMX combined with standard care vs. standard care alone in a 2:1 randomized trial of 150 patients, utilizing Bayesian statistics to assess its effectiveness. The trial methods are detailed in the Critical Care publication “Bayesian methods: a potential path forward for sepsis trials." https://doi.org/10.1186/s13054-023-04717-x